Biofil Chemicals & Pharmaceuticals Ltd.
•₹ 30.26-1.69%
2026-08-21
PROS
- Company is almost debt free
- Company comfortably covers its interest (20.9x coverage)
CONS
- Operating cash flow has been negative in recent years
- Recent results are weak - TTM profit is down 90.8% versus prior year
- Receivables are growing faster than sales - a possible quality concern
- A large part of profit comes from other income (41.5% of PBT)
- Company has a low return on capital employed of 4.6%
- Company has a low return on equity of 3.4% over last 3 years
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | ADANIENT | 2979.00 | 54.17 | 403273.96 | 0.04 | -1461.54 | -249.67 | 32923.98 | 49.92 | 13.30 | 15.57 |
| 2. | AEGISLOG | 1363.65 | 38.25 | 47864.12 | 0.64 | 544.84 | 210.70 | 2356.86 | 37.07 | 19.76 | 30.28 |
| 3. | PREMIERENE | 1008.00 | 27.48 | 45758.31 | 0.10 | 471.92 | 53.32 | 2462.59 | 35.25 | 41.97 | 29.03 |
| 4. | CPPLUS | 3307.45 | 81.98 | 39127.28 | 0.05 | 142.20 | 332.51 | 1402.42 | 89.51 | 29.48 | 14.52 |
| 5. | REDINGTON | 334.90 | 15.39 | 26181.63 | 1.79 | 453.49 | 94.65 | 34922.47 | 34.57 | 18.96 | 2.03 |
| 6. | HONASA | 476.90 | 62.48 | 15548.09 | 0.63 | 90.45 | 118.87 | 755.95 | 27.00 | 8.99 | 14.58 |
| 7. | LLOYDSENT | 78.59 | 106.84 | 11997.17 | 0.19 | 109.98 | -55.77 | 563.03 | 70.15 | 12.84 | 18.07 |
| 8. | SGMART | 805.80 | 81.69 | 10155.92 | 0.00 | 455.80 | 1310.71 | 13085.70 | 1044.08 | 11.45 | 4.49 |
| 9. | MMTC | 62.10 | 20.82 | 9315.00 | 0.00 | 104.24 | 135.52 | 0.68 | -50.00 | 6.90 | -1423.53 |
| 10. | CELLO | 358.45 | 25.31 | 7917.62 | 0.42 | 73.40 | -8.99 | 526.72 | -0.43 | 17.15 | 18.80 |
| 11. | EBGNG | 588.80 | 47.13 | 6713.00 | 0.00 | 289.30 | 1462.10 | 4124.61 | 1220.81 | 20.14 | 11.97 |
| 12. | BIOFILCHEM | 31.16 | 0.00 | 50.71 | 0.00 | 0.11 | -95.48 | 12.35 | 92.07 | 4.08 | 1.13 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 17 | 5 | 15 | 8 | 2 | 14 | 8 | 6 | 14 | 1 | 8 | 12 | |
| 2 | 17 | 5 | 15 | 8 | 2 | 14 | 8 | 6 | 13 | 1 | 7 | 12 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | |
| Tax % | 25.00% | 20.00% | 18.18% | 11.11% | 26.09% | 33.33% | 27.27% | 20.00% | 12.68% | 27.27% | 27.27% | 55.32% | 18.66% |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 2
- 2
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 25.00%
- Net Profit
- 0
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 17
- 17
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 20.00%
- Net Profit
- 0
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 5
- 5
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 18.18%
- Net Profit
- 0
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 15
- 15
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 11.11%
- Net Profit
- 0
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 8
- 8
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 26.09%
- Net Profit
- 0
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 2
- 2
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 33.33%
- Net Profit
- 0
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 14
- 14
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 27.27%
- Net Profit
- 0
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 8
- 8
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 20.00%
- Net Profit
- 0
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 6
- 6
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 0
- Depreciation
- 0
- 3
- Tax %
- 12.68%
- Net Profit
- 2
- 1
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 14
- 13
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 27.27%
- Net Profit
- 0
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 1
- 1
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 27.27%
- Net Profit
- 0
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 8
- 7
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 55.32%
- Net Profit
- 0
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 12
- 12
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 18.66%
- Net Profit
- 0
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13 | 13 | 12 | 23 | 30 | 36 | 22 | 30 | 40 | 33 | 34 | |
| 12 | 11 | 11 | 22 | 28 | 34 | 21 | 29 | 39 | 33 | 34 | |
| Operating Profit | 1 | 3 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | — |
| OPM % | 11 | 21 | 8 | 5 | 7 | 7 | 7 | 4 | 3 | 3 | — |
| Other Income | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | |
| Tax % | 20 | 22 | 20 | 19 | 18 | 35 | 31 | 29 | 18 | 24 | 42 |
| Net Profit | 1 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| EPS | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | — |
Mar 2016
- 13
- 12
- Operating Profit
- 1
- OPM %
- 11
- Other Income
- 1
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 20
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2017
- 13
- 11
- Operating Profit
- 3
- OPM %
- 21
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 2
- Tax %
- 22
- Net Profit
- 2
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2018
- 12
- 11
- Operating Profit
- 1
- OPM %
- 8
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 20
- Net Profit
- 0
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2019
- 23
- 22
- Operating Profit
- 1
- OPM %
- 5
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 19
- Net Profit
- 0
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2020
- 30
- 28
- Operating Profit
- 2
- OPM %
- 7
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 18
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2021
- 36
- 34
- Operating Profit
- 2
- OPM %
- 7
- Other Income
- 1
- Interest
- 0
- Depreciation
- 0
- 2
- Tax %
- 35
- Net Profit
- 1
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2022
- 22
- 21
- Operating Profit
- 1
- OPM %
- 7
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 31
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2023
- 30
- 29
- Operating Profit
- 1
- OPM %
- 4
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 29
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2024
- 40
- 39
- Operating Profit
- 1
- OPM %
- 3
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 18
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2025
- 33
- 33
- Operating Profit
- 1
- OPM %
- 3
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 24
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
TTM
- 34
- 34
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 42
- Net Profit
- 0
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 19%
- 5 Years:
- 2%
- 3 Years:
- 14%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- -1%
- 5 Years:
- -14%
- 3 Years:
- -7%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- -13%
- 3 Years:
- -12%
- 1 Year:
- -29%
RETURN ON EQUITY
- 10 Years:
- 7%
- 5 Years:
- 5%
- 3 Years:
- 3%
- Last Year:
- 3%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| -5 | -4 | -3 | -3 | -1 | -0 | 1 | 1 | 2 | 3 | |
| 1 | 1 | 2 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | |
| Trade Payables | 12 | 7 | 9 | 9 | 26 | 16 | 1 | 13 | 28 | 31 |
| Other Liabilities | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Total Liabilities | 24 | 22 | 24 | 24 | 42 | 33 | 19 | 31 | 47 | 51 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 9 | 9 | 9 | 10 | 10 | 10 | 9 | 9 | 9 | 8 | |
| 0 | 0 | 1 | 1 | 2 | 4 | 1 | 1 | 3 | 3 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33 | 38 | |
| Cash & Bank | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
| 15 | 12 | 14 | 13 | 30 | 19 | 8 | 21 | 1 | 1 | |
| Total Assets | 24 | 22 | 24 | 24 | 42 | 33 | 19 | 31 | 47 | 51 |
| Total Debt | 1 | 1 | 2 | 2 | 1 | 0 | 0 | 1 | 0 | 0 |
| Net Working Capital | 2 | 4 | 4 | 3 | 5 | 7 | 8 | 9 | 10 | 11 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 4.39 | 7.80 | 8.09 | 8.39 | 9.15 | 9.91 | 10.35 | 10.63 | 11.19 | 11.54 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 1 | 1 | 2 | 2 | 1 | 0 | 0 | 1 | 0 | 0 |
| Net Working Capital | 2 | 4 | 4 | 3 | 5 | 7 | 8 | 9 | 10 | 11 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 4.39 | 7.80 | 8.09 | 8.39 | 9.15 | 9.91 | 10.35 | 10.63 | 11.19 | 11.54 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2016
- Equity Capital
- 16
- -5
- 1
- Trade Payables
- 12
- Other Liabilities
- 0
- Total Liabilities
- 24
- 9
- 0
- 0
- Cash & Bank
- 0
- 15
- Total Assets
- 24
- Total Debt
- 1
- Net Working Capital
- 2
- Contingent Liabilities
- 0
- Book Value per Share
- 4.39
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- 2
- Contingent Liabilities
- 0
- Book Value per Share
- 4.39
- Face Value
- 10.00
Mar 2017
- Equity Capital
- 16
- -4
- 1
- Trade Payables
- 7
- Other Liabilities
- 1
- Total Liabilities
- 22
- 9
- 0
- 0
- Cash & Bank
- 0
- 12
- Total Assets
- 22
- Total Debt
- 1
- Net Working Capital
- 4
- Contingent Liabilities
- 0
- Book Value per Share
- 7.80
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- 4
- Contingent Liabilities
- 0
- Book Value per Share
- 7.80
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 16
- -3
- 2
- Trade Payables
- 9
- Other Liabilities
- 0
- Total Liabilities
- 24
- 9
- 1
- 0
- Cash & Bank
- 0
- 14
- Total Assets
- 24
- Total Debt
- 2
- Net Working Capital
- 4
- Contingent Liabilities
- 0
- Book Value per Share
- 8.09
- Face Value
- 10.00
- Total Debt
- 2
- Net Working Capital
- 4
- Contingent Liabilities
- 0
- Book Value per Share
- 8.09
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 16
- -3
- 2
- Trade Payables
- 9
- Other Liabilities
- 0
- Total Liabilities
- 24
- 10
- 1
- 0
- Cash & Bank
- 0
- 13
- Total Assets
- 24
- Total Debt
- 2
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 8.39
- Face Value
- 10.00
- Total Debt
- 2
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 8.39
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 16
- -1
- 1
- Trade Payables
- 26
- Other Liabilities
- 0
- Total Liabilities
- 42
- 10
- 2
- 0
- Cash & Bank
- 0
- 30
- Total Assets
- 42
- Total Debt
- 1
- Net Working Capital
- 5
- Contingent Liabilities
- 0
- Book Value per Share
- 9.15
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- 5
- Contingent Liabilities
- 0
- Book Value per Share
- 9.15
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 16
- -0
- 0
- Trade Payables
- 16
- Other Liabilities
- 1
- Total Liabilities
- 33
- 10
- 4
- 0
- Cash & Bank
- 0
- 19
- Total Assets
- 33
- Total Debt
- 0
- Net Working Capital
- 7
- Contingent Liabilities
- 0
- Book Value per Share
- 9.91
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 7
- Contingent Liabilities
- 0
- Book Value per Share
- 9.91
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 16
- 1
- 0
- Trade Payables
- 1
- Other Liabilities
- 1
- Total Liabilities
- 19
- 9
- 1
- 0
- Cash & Bank
- 0
- 8
- Total Assets
- 19
- Total Debt
- 0
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 10.35
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 10.35
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 16
- 1
- 1
- Trade Payables
- 13
- Other Liabilities
- 1
- Total Liabilities
- 31
- 9
- 1
- 0
- Cash & Bank
- 0
- 21
- Total Assets
- 31
- Total Debt
- 1
- Net Working Capital
- 9
- Contingent Liabilities
- 0
- Book Value per Share
- 10.63
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- 9
- Contingent Liabilities
- 0
- Book Value per Share
- 10.63
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 16
- 2
- 0
- Trade Payables
- 28
- Other Liabilities
- 1
- Total Liabilities
- 47
- 9
- 3
- 33
- Cash & Bank
- 2
- 1
- Total Assets
- 47
- Total Debt
- 0
- Net Working Capital
- 10
- Contingent Liabilities
- 0
- Book Value per Share
- 11.19
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 10
- Contingent Liabilities
- 0
- Book Value per Share
- 11.19
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 16
- 3
- 0
- Trade Payables
- 31
- Other Liabilities
- 1
- Total Liabilities
- 51
- 8
- 3
- 38
- Cash & Bank
- 0
- 1
- Total Assets
- 51
- Total Debt
- 0
- Net Working Capital
- 11
- Contingent Liabilities
- 0
- Book Value per Share
- 11.54
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 11
- Contingent Liabilities
- 0
- Book Value per Share
- 11.54
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 0 | 1 | 1 | 1 | -0 | -0 | 2 | -2 | |
| Cash from Investing | -0 | -0 | -0 | -1 | -0 | -0 | -0 | -0 | -0 | -0 |
| Cash from Financing | 0 | -0 | -0 | -0 | -1 | -1 | -0 | 0 | -0 | -0 |
| 0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 | 2 | -2 | |
| Free Cash Flow | -0 | 1 | 0 | -0 | 1 | 1 | -0 | -0 | 2 | -2 |
| OCF / Net Profit | 0.17 | 0.40 | 0.98 | 2.60 | 0.74 | 0.89 | -0.31 | -0.20 | 3.38 | -3.45 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 1 | 4 | 1 |
| OCF / Net Profit | 0.17 | 0.40 | 0.98 | 2.60 | 0.74 | 0.89 | -0.31 | -0.20 | 3.38 | -3.45 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 1 | 4 | 1 |
Mar 2016
- 0
- Cash from Investing
- -0
- Cash from Financing
- 0
- 0
- Free Cash Flow
- -0
- OCF / Net Profit
- 0.17
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.17
- Cumulative 5-Year FCF
- 0
Mar 2017
- 1
- Cash from Investing
- -0
- Cash from Financing
- -0
- 0
- Free Cash Flow
- 1
- OCF / Net Profit
- 0.40
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.40
- Cumulative 5-Year FCF
- 0
Mar 2018
- 0
- Cash from Investing
- -0
- Cash from Financing
- -0
- 0
- Free Cash Flow
- 0
- OCF / Net Profit
- 0.98
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.98
- Cumulative 5-Year FCF
- 0
Mar 2019
- 1
- Cash from Investing
- -1
- Cash from Financing
- -0
- -0
- Free Cash Flow
- -0
- OCF / Net Profit
- 2.60
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.60
- Cumulative 5-Year FCF
- 0
Mar 2020
- 1
- Cash from Investing
- -0
- Cash from Financing
- -1
- 0
- Free Cash Flow
- 1
- OCF / Net Profit
- 0.74
- Cumulative 5-Year FCF
- 1
- OCF / Net Profit
- 0.74
- Cumulative 5-Year FCF
- 1
Mar 2021
- 1
- Cash from Investing
- -0
- Cash from Financing
- -1
- 0
- Free Cash Flow
- 1
- OCF / Net Profit
- 0.89
- Cumulative 5-Year FCF
- 2
- OCF / Net Profit
- 0.89
- Cumulative 5-Year FCF
- 2
Mar 2022
- -0
- Cash from Investing
- -0
- Cash from Financing
- -0
- -0
- Free Cash Flow
- -0
- OCF / Net Profit
- -0.31
- Cumulative 5-Year FCF
- 1
- OCF / Net Profit
- -0.31
- Cumulative 5-Year FCF
- 1
Mar 2023
- -0
- Cash from Investing
- -0
- Cash from Financing
- 0
- -0
- Free Cash Flow
- -0
- OCF / Net Profit
- -0.20
- Cumulative 5-Year FCF
- 1
- OCF / Net Profit
- -0.20
- Cumulative 5-Year FCF
- 1
Mar 2024
- 2
- Cash from Investing
- -0
- Cash from Financing
- -0
- 2
- Free Cash Flow
- 2
- OCF / Net Profit
- 3.38
- Cumulative 5-Year FCF
- 4
- OCF / Net Profit
- 3.38
- Cumulative 5-Year FCF
- 4
Mar 2025
- -2
- Cash from Investing
- -0
- Cash from Financing
- -0
- -2
- Free Cash Flow
- -2
- OCF / Net Profit
- -3.45
- Cumulative 5-Year FCF
- 1
- OCF / Net Profit
- -3.45
- Cumulative 5-Year FCF
- 1
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 0.48 | 1.10 | 0.29 | 0.30 | 0.74 | 0.76 | 0.43 | 0.34 | 0.44 | 0.34 |
| Book Value (₹) | 4.39 | 7.80 | 8.09 | 8.39 | 9.15 | 9.91 | 10.35 | 10.63 | 11.19 | 11.54 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 0.64 | 1.28 | 0.47 | 0.52 | 0.99 | 1.02 | 0.69 | 0.61 | 0.68 | 0.58 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 10.61% | 20.50% | 8.39% | 4.86% | 6.72% | 6.71% | 6.63% | 4.21% | 2.04% | 2.54% |
| Net Margin % | 5.94% | 13.34% | 3.81% | 2.09% | 4.07% | 3.47% | 3.12% | 1.87% | 1.77% | 1.67% |
| ROE % | 13.28% | 18.09% | 3.64% | 3.60% | 8.46% | 8.01% | 4.24% | 3.28% | 4.00% | 3.02% |
| ROCE % | 14.04% | 21.86% | 5.13% | 5.06% | 10.12% | 12.18% | 6.23% | 4.76% | 4.97% | 4.08% |
| 4.13% | 7.81% | 2.05% | 1.99% | 3.63% | 3.28% | 2.69% | 2.24% | 1.81% | 1.14% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 244 | 345 | 361 | 197 | 257 | 240 | 199 | 168 | 244 | 390 |
| Inventory Days | 4 | 4 | 18 | 17 | 18 | 31 | 46 | 15 | 17 | 32 |
| Payable Days | 238 | 401 | 303 | 162 | 249 | 235 | 154 | 88 | 196 | 346 |
| 10 | -52 | 75 | 53 | 25 | 35 | 91 | 95 | 66 | 76 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.19x | 0.11x | 0.12x | 0.12x | 0.08x | 0.03x | 0.03x | 0.03x | 0.02x | 0.03x |
| Interest Coverage (x) | 7.46x | 15.12x | 4.86x | 4.70x | 12.96x | 29.18x | 26.00x | 19.66x | 21.85x | 20.95x |
| 1.15x | 1.39x | 1.36x | 1.32x | 1.17x | 1.40x | 6.23x | 1.63x | 1.35x | 1.34x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 124.71% | 2.15% | -8.13% | 87.12% | 28.37% | 20.41% | -37.39% | 34.19% | 33.29% | -16.57% |
| Operating Profit Growth % | 16.89% | 97.37% | -62.41% | 8.49% | 77.33% | 20.26% | -38.18% | -14.73% | 3.29% | -11.76% |
| Net Profit Growth % | 33.29% | 129.25% | -73.77% | 2.46% | 150.30% | 2.83% | -43.74% | -19.76% | 26.55% | -21.36% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 26.54% | -21.36% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 138.50x | 120.02x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 5.40x | 3.56x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 73.79x | 58.26x |
Mar 2016
- EPS (₹)
- 0.48
- Book Value (₹)
- 4.39
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.64
- Operating Margin %
- 10.61%
- Net Margin %
- 5.94%
- ROE %
- 13.28%
- ROCE %
- 14.04%
- 4.13%
- Debtor Days
- 244
- Inventory Days
- 4
- Payable Days
- 238
- 10
- Debt to Equity (x)
- 0.19x
- Interest Coverage (x)
- 7.46x
- 1.15x
- Revenue Growth %
- 124.71%
- Operating Profit Growth %
- 16.89%
- Net Profit Growth %
- 33.29%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- 1.10
- Book Value (₹)
- 7.80
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.28
- Operating Margin %
- 20.50%
- Net Margin %
- 13.34%
- ROE %
- 18.09%
- ROCE %
- 21.86%
- 7.81%
- Debtor Days
- 345
- Inventory Days
- 4
- Payable Days
- 401
- -52
- Debt to Equity (x)
- 0.11x
- Interest Coverage (x)
- 15.12x
- 1.39x
- Revenue Growth %
- 2.15%
- Operating Profit Growth %
- 97.37%
- Net Profit Growth %
- 129.25%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 0.29
- Book Value (₹)
- 8.09
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.47
- Operating Margin %
- 8.39%
- Net Margin %
- 3.81%
- ROE %
- 3.64%
- ROCE %
- 5.13%
- 2.05%
- Debtor Days
- 361
- Inventory Days
- 18
- Payable Days
- 303
- 75
- Debt to Equity (x)
- 0.12x
- Interest Coverage (x)
- 4.86x
- 1.36x
- Revenue Growth %
- -8.13%
- Operating Profit Growth %
- -62.41%
- Net Profit Growth %
- -73.77%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 0.30
- Book Value (₹)
- 8.39
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.52
- Operating Margin %
- 4.86%
- Net Margin %
- 2.09%
- ROE %
- 3.60%
- ROCE %
- 5.06%
- 1.99%
- Debtor Days
- 197
- Inventory Days
- 17
- Payable Days
- 162
- 53
- Debt to Equity (x)
- 0.12x
- Interest Coverage (x)
- 4.70x
- 1.32x
- Revenue Growth %
- 87.12%
- Operating Profit Growth %
- 8.49%
- Net Profit Growth %
- 2.46%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 0.74
- Book Value (₹)
- 9.15
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.99
- Operating Margin %
- 6.72%
- Net Margin %
- 4.07%
- ROE %
- 8.46%
- ROCE %
- 10.12%
- 3.63%
- Debtor Days
- 257
- Inventory Days
- 18
- Payable Days
- 249
- 25
- Debt to Equity (x)
- 0.08x
- Interest Coverage (x)
- 12.96x
- 1.17x
- Revenue Growth %
- 28.37%
- Operating Profit Growth %
- 77.33%
- Net Profit Growth %
- 150.30%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 0.76
- Book Value (₹)
- 9.91
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.02
- Operating Margin %
- 6.71%
- Net Margin %
- 3.47%
- ROE %
- 8.01%
- ROCE %
- 12.18%
- 3.28%
- Debtor Days
- 240
- Inventory Days
- 31
- Payable Days
- 235
- 35
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 29.18x
- 1.40x
- Revenue Growth %
- 20.41%
- Operating Profit Growth %
- 20.26%
- Net Profit Growth %
- 2.83%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 0.43
- Book Value (₹)
- 10.35
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.69
- Operating Margin %
- 6.63%
- Net Margin %
- 3.12%
- ROE %
- 4.24%
- ROCE %
- 6.23%
- 2.69%
- Debtor Days
- 199
- Inventory Days
- 46
- Payable Days
- 154
- 91
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 26.00x
- 6.23x
- Revenue Growth %
- -37.39%
- Operating Profit Growth %
- -38.18%
- Net Profit Growth %
- -43.74%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 0.34
- Book Value (₹)
- 10.63
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.61
- Operating Margin %
- 4.21%
- Net Margin %
- 1.87%
- ROE %
- 3.28%
- ROCE %
- 4.76%
- 2.24%
- Debtor Days
- 168
- Inventory Days
- 15
- Payable Days
- 88
- 95
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 19.66x
- 1.63x
- Revenue Growth %
- 34.19%
- Operating Profit Growth %
- -14.73%
- Net Profit Growth %
- -19.76%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 0.44
- Book Value (₹)
- 11.19
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.68
- Operating Margin %
- 2.04%
- Net Margin %
- 1.77%
- ROE %
- 4.00%
- ROCE %
- 4.97%
- 1.81%
- Debtor Days
- 244
- Inventory Days
- 17
- Payable Days
- 196
- 66
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 21.85x
- 1.35x
- Revenue Growth %
- 33.29%
- Operating Profit Growth %
- 3.29%
- Net Profit Growth %
- 26.55%
- 26.54%
- P/E (x)
- 138.50x
- P/B (x)
- 5.40x
- Dividend Yield %
- 0.00%
- 73.79x
Mar 2025
- EPS (₹)
- 0.34
- Book Value (₹)
- 11.54
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.58
- Operating Margin %
- 2.54%
- Net Margin %
- 1.67%
- ROE %
- 3.02%
- ROCE %
- 4.08%
- 1.14%
- Debtor Days
- 390
- Inventory Days
- 32
- Payable Days
- 346
- 76
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 20.95x
- 1.34x
- Revenue Growth %
- -16.57%
- Operating Profit Growth %
- -11.76%
- Net Profit Growth %
- -21.36%
- -21.36%
- P/E (x)
- 120.02x
- P/B (x)
- 3.56x
- Dividend Yield %
- 0.00%
- 58.26x
Documents
Announcements
- Copy of Newspaper Publication
2026-08-19 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication of Notice of 41st AGM through Video Conferencing ( VC )/ Other Audio Visual Means ( OAVM )
- Copy of Newspaper Publication
2026-08-12 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.